Global /China /Healthcare /Drug Manufacturers - General /002873

Guiyang Xintian Pharmaceutical Co.,Ltd.

002873

• SHE: 002873 • Delayed

10.10CNY 2.9%

1.49 USD

As of 22 June 2026, Guiyang Xintian Pharmaceutical Co.,Ltd. has a market cap of $341.32M USD, ranking #17787 globally and #5496 in China. It ranks #1609 in the Healthcare sector, and #579 in the Drug Manufacturers - General industry.

Global Rank

17787

Country Rank

5496

Sector Rank

1609

Industry Rank

579

Key Stats

Market Cap

$341.32MUSD

2.31B CNY

Enterprise Value

$414.46MUSD

2.81B CNY

Revenue (TTM)

$110.75MUSD

749.72M CNY

EBITDA (TTM)

$8.23MUSD

55.74M CNY

Net Income (TTM)

$1.35MUSD

9.11M CNY

EBITDA Margin

7.4%

Profit Margin

1.2%

PE Ratio

253.7

PS Ratio

3.1

PB Ratio

1.8

EV/EBITDA

46.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Da Lun Dong open_in_new

Employees

1,388

Founded

1995

Website

gyxtyy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.9%	3.2%	-2%	-4.1%	-8.2%	-1%	16%	-28%	11%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002873 贵阳新天药业股份有限公司 Class A ISIN: CNE100002QB5 Shares Out.: Shares Outstanding: 235.298M¹ Shares Float: 234.745M² TV: TradingView: SZSE: 002873 SA: Stock Analysis: SHE: 002873 YF: Yahoo Finance: 002873.SZ GF: Google Finance: SHE: 002873 BA: Barron's: 002873 MS: Morningstar: XSHE: 002873	10.10 CNY	TV: TradingView: SZSE: 002873 SA: Stock Analysis: SHE: 002873 YF: Yahoo Finance: 002873.SZ GF: Google Finance: SHE: 002873 BA: Barron's: 002873 MS: Morningstar: XSHE: 002873

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Guiyang Xintian Pharmaceutical Co.,Ltd.

Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of gynecological, urinary tract, breast, thyroid, cardiovascular, anti-tumor, and dental diseases, as well as for oral health; and cold, heat-clearing, and blood-tonifying remedies. The company also engages in research and development; consulting; scientific research; accommodation and catering; technology promotion; pharmaceutical research and development; and health food processing activities. Guiyang Xintian Pharmaceutical Co.,Ltd. was founded in 1995 and is based in Guiyang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.9B 364.89B CNY 16K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.69B 336.36B CNY 14K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 8K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 5K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 5K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 5K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 223K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 160K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 106K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 93K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 83K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 80K%	15.1	United States

chevron_leftBack